Positive Outlook for Rocket Pharmaceuticals Amidst Significant Trial Progress and Regulatory Engagement
TD Cowen analyst Tyler Van Buren has maintained their bullish stance on RCKT stock, giving a Buy rating today. Tyler Van Buren has given his ...
Rocket Pharmaceuticals Positioned for Growth with Promising Pipeline and Strategic Advancements
William Blair analyst Sami Corwin has maintained their bullish stance on RCKT stock, giving a Buy rating yesterday. Sami Corwin has given his ...